Hardev Pandha

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2018-12 Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants in NATURE COMMUNICATIONS
  • 2018-12 Engrailed-2 (EN2) – a novel biomarker in epithelial ovarian cancer in BMC CANCER
  • 2018-07 Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci in NATURE GENETICS
  • 2018-06 Synergistic antitumour effects of rapamycin and oncolytic reovirus in CANCER GENE THERAPY
  • 2017-01 Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy in GENE THERAPY
  • 2016-12 HOX transcription factors are potential targets and markers in malignant mesothelioma in BMC CANCER
  • 2016-12 Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort in BMC MEDICINE
  • 2016-11 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-11 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-10 Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study in BRITISH JOURNAL OF CANCER
  • 2016-08 Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium in BRITISH JOURNAL OF CANCER
  • 2016-04 Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array in BRITISH JOURNAL OF CANCER
  • 2016-04 Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer in GENE THERAPY
  • 2015-12 Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21 in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-11 The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium in CANCER CAUSES & CONTROL
  • 2015-09 Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015 in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2014-12 Targeting HOX transcription factors in prostate cancer in BMC UROLOGY
  • 2014-10 A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer in NATURE GENETICS
  • 2014-03 Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling in ONCOGENE
  • 2014-02 The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2013-12 Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence in NATURE MEDICINE
  • 2013-05 Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy in GENE THERAPY
  • 2013-05 The role of HOX genes in normal hematopoiesis and acute leukemia in LEUKEMIA
  • 2013-01 Measles virus causes immunogenic cell death in human melanoma in GENE THERAPY
  • 2013 Presentation and Symptomatology of Prostate Cancer in PROSTATE CANCER: A COMPREHENSIVE PERSPECTIVE
  • 2012-12 Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway in BMC CANCER
  • 2012-11 Targeting the HOX/PBX dimer in breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-09 Corrigendum: Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors in NATURE MEDICINE
  • 2012-01 Are we ready to start studies of Th17 cell manipulation as a therapy for cancer? in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2012-01 Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer in BRITISH JOURNAL OF CANCER
  • 2011-12 HOX genes in ovarian cancer in JOURNAL OF OVARIAN RESEARCH
  • 2011-12 Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer in BMC CANCER
  • 2011-12 Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming in MOLECULAR CANCER
  • 2011-07 Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors in NATURE MEDICINE
  • 2011-07 The roles of cell surface attachment molecules and coagulation Factor X in adenovirus 5-mediated gene transfer in pancreatic cancer cells in CANCER GENE THERAPY
  • 2010-12 Targeting HOX and PBX transcription factors in ovarian cancer in BMC CANCER
  • 2010-12 Differential effects of Paclitaxel on dendritic cell function in BMC IMMUNOLOGY
  • 2010-12 Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo in BMC CANCER
  • 2010-09 Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells in LEUKEMIA
  • 2009-05 Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity in GENE THERAPY
  • 2009-03 Prostate cancer chemotherapy in the era of targeted therapy in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2009-02 HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer) in BRITISH JOURNAL OF CANCER
  • 2008-09 Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma in GENE THERAPY
  • 2008-06 Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial in GENE THERAPY
  • 2008-03 Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo in GENE THERAPY
  • 2006-12 Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPK in MOLECULAR CANCER
  • 2005-12 Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.5475.3", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "https://www.grid.ac/institutes/grid.430814.a", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.464688.0", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.413629.b", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.264200.2", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.4991.5", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.411065.7", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.6906.9", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.5072.0", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.5491.9", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.18886.3f", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.415490.d", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.241116.1", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.66875.3a", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.473108.9", 
            "type": "Organization"
        "familyName": "Pandha", 
        "givenName": "Hardev", 
        "id": "sg:person.01215757170.08", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:43", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_476.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01215757170.08'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01215757170.08'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01215757170.08'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01215757170.08'


    This table displays all metadata directly associated to this object as RDF triples.

    46 TRIPLES      10 PREDICATES      26 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01215757170.08 schema:affiliation Nb72364555d6840a3a9138bbd6d1fb720
    2 https://www.grid.ac/institutes/grid.18886.3f
    3 https://www.grid.ac/institutes/grid.241116.1
    4 https://www.grid.ac/institutes/grid.264200.2
    5 https://www.grid.ac/institutes/grid.411065.7
    6 https://www.grid.ac/institutes/grid.413629.b
    7 https://www.grid.ac/institutes/grid.415490.d
    8 https://www.grid.ac/institutes/grid.430814.a
    9 https://www.grid.ac/institutes/grid.464688.0
    10 https://www.grid.ac/institutes/grid.473108.9
    11 https://www.grid.ac/institutes/grid.4991.5
    12 https://www.grid.ac/institutes/grid.5072.0
    13 https://www.grid.ac/institutes/grid.5491.9
    14 https://www.grid.ac/institutes/grid.66875.3a
    15 https://www.grid.ac/institutes/grid.6906.9
    16 https://www.grid.ac/institutes/grid.7445.2
    17 schema:familyName Pandha
    18 schema:givenName Hardev
    19 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215757170.08
    20 schema:sdDatePublished 2019-03-07T14:43
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher N30aeb5171e8848afa8e0a2c30e99f965
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset persons
    25 rdf:type schema:Person
    26 N30aeb5171e8848afa8e0a2c30e99f965 schema:name Springer Nature - SN SciGraph project
    27 rdf:type schema:Organization
    28 Nb72364555d6840a3a9138bbd6d1fb720 schema:affiliation https://www.grid.ac/institutes/grid.5475.3
    29 sgo:isCurrent true
    30 rdf:type schema:OrganizationRole
    31 https://www.grid.ac/institutes/grid.18886.3f schema:Organization
    32 https://www.grid.ac/institutes/grid.241116.1 schema:Organization
    33 https://www.grid.ac/institutes/grid.264200.2 schema:Organization
    34 https://www.grid.ac/institutes/grid.411065.7 schema:Organization
    35 https://www.grid.ac/institutes/grid.413629.b schema:Organization
    36 https://www.grid.ac/institutes/grid.415490.d schema:Organization
    37 https://www.grid.ac/institutes/grid.430814.a schema:Organization
    38 https://www.grid.ac/institutes/grid.464688.0 schema:Organization
    39 https://www.grid.ac/institutes/grid.473108.9 schema:Organization
    40 https://www.grid.ac/institutes/grid.4991.5 schema:Organization
    41 https://www.grid.ac/institutes/grid.5072.0 schema:Organization
    42 https://www.grid.ac/institutes/grid.5475.3 schema:Organization
    43 https://www.grid.ac/institutes/grid.5491.9 schema:Organization
    44 https://www.grid.ac/institutes/grid.66875.3a schema:Organization
    45 https://www.grid.ac/institutes/grid.6906.9 schema:Organization
    46 https://www.grid.ac/institutes/grid.7445.2 schema:Organization

    Preview window. Press ESC to close (or click here)